Ubs Group Ag Anixa Biosciences Inc Call Options Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
64Shares Held
5.37MCall Options Held
24.5KPut Options Held
23.4K-
Vanguard Group Inc Valley Forge, PA1.39MShares$4.47 Million0.0% of portfolio
-
Laird Norton Trust Company, LLC622KShares$2 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.97 Million0.01% of portfolio
-
Mission Wealth Management, LP370KShares$1.19 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA340KShares$1.09 Million0.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $98.4M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...